---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-064380"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2024-03-11T23:59:59+00:00"
generated_at: "2026-06-04T23:58:10.871136+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# MindMed prices $175M combined offering of common shares at $6.00 each

## Summary
- Underwritten offering of 16,666,667 common shares at $6.00 per share with net proceeds of ~$93.8M.
- Concurrent private placement of 12,500,000 common shares at $6.00 per share to Deep Track Capital and Commodore Capital, net proceeds ~$70.3M.
- Combined gross proceeds expected to be ~$175M; closing expected on March 11, 2024.
- Proceeds will be used for R&D of product candidates, working capital, and general corporate purposes.

## SEC filing metadata
- accession: 0001193125-24-064380
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2024-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000119312524064380/0001193125-24-064380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000119312524064380/d787577d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-064380
- JSON: https://secwatch.observer/filing/0001193125-24-064380.json
- Plain text: https://secwatch.observer/filing/0001193125-24-064380.txt

## Key facts
- Material Agreements
  Definium Therapeutics, Inc. entered into Underwriting Agreement with Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein valued at approximately $93.8 million (effective 2024-03-07).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein
  - Value: approximately $93.8 million
  - Effective: 2024-03-07
  source text: On March 7, 2024, Mind Medicine (MindMed) Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein (the “Underwriters”), in connection with the issuance and sale by the Company in an underwritten offering (the “Offering”) of 16,666,667 common shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/1813814/000119312524064380/0001193125-24-064380-index.htm
- Material Agreements
  Definium Therapeutics, Inc. entered into Purchase Agreement with certain investors valued at approximately $70.3 million (effective 2024-03-07).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain investors
  - Value: approximately $70.3 million
  - Effective: 2024-03-07
  source text: Also on March 7, 2024, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors (the “Investors”), pursuant to which the Investors agreed to purchase, and the Company agreed to sell 12,500,000 common shares (the “Private Placement Shares”), at a price of $6.00 per Private Placement Share, in a private placement transaction (the “Private Placement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1813814/000119312524064380/0001193125-24-064380-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.